Download FREE Report Sample
Download Free sampleUrokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.
Urokinase Market contains market size and forecasts of Urokinase in global, including the following market information:
Global Urokinase Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Urokinase Market Sales, 2017-2022, 2023-2028, (BIU)
Global top five Urokinase companies in 2021 (%)
The global Urokinase market was valued at 46 million in 2021 and is projected to reach US$ 65 million by 2028, at a CAGR of 5.0% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urokinase Powder Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Urokinase include Syner-Med, Wanhua Biochem, Jiangxi Haoran Bio-Pharma, Jiangsu Aidea Pharmaceutical, Techpool, Microbic Biosystems and LIVZON, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Urokinase manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Urokinase Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (BIU)
Global Urokinase Market Segment Percentages, by Type, 2021 (%)
Urokinase Powder
Urokinase Solution
Global Urokinase Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (BIU)
Global Urokinase Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Urokinase Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (BIU)
Global Urokinase Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Urokinase revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Urokinase revenues share in global market, 2021 (%)
Key companies Urokinase sales in global market, 2017-2022 (Estimated), (BIU)
Key companies Urokinase sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Syner-Med
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical
Techpool
Microbic Biosystems
LIVZON
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
